Our data suggest that a gradient of CCL2 attracts monocytes/macrophages towards the metastatic tumor microenvironment where they are exposed to high levels of CCL2 and are prompted to secrete another chemokine CCL3. The gene discussed is CCL2; the disease is neoplasm.